10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
The COVID-19 pandemic has been a considerable source of discussion and, despite multiple publication...
Read More >
A February 2020 jury verdict against county music star Martina McBride’s production company highlig...
Read More >
Following Hutton v Wilson, Part 8 challenges to adjudication have become less common. However, in Wi...
Read More >
As the number of cases of the 2019 Novel Coronavirus (Coronavirus) continues to rise, many employers...
Read More >
Trucking companies will no longer need to pay their drivers for certain off-duty time, potentially i...
Read More >
Part One of this post discussed an NRLB Office of General Counsel Advice Memorandum which determined...
Read More >